Recombinant Human UL128 Protein，His

UL128 is a glycoprotein encoded by the human cytomegalovirus (HCMV), which is a member of the Herpesviridae family. Research on UL128 has attracted significant attention due to its critical role in viral entry and immune evasion. This protein is part of a larger complex that assists HCMV in infecting host cells, particularly endothelial and epithelial cells, which are key targets during infection. The UL128 protein has been shown to mediate the virus's interaction with specific cell surface receptors, facilitating fusion and uptake of the viral particle. Additionally, UL128 is implicated in the immune response, as it can modulate the host's immune recognition, thereby helping the virus evade detection by the immune system. Studies indicate that UL128 may also contribute to the establishment of latent infection, a hallmark of HCMV, posing challenges for vaccine development and therapeutic interventions. Consequently, understanding the structure, function, and interactions of UL128 is crucial for developing effective strategies to combat HCMV infections, which pose significant risks for immunocompromised individuals and can lead to severe complications in congenital infections. Research efforts have focused not only on the protein's role in virulence but also on its potential as a target for vaccine development, given its surface localization and involvement in the immune response. Overall, UL128 serves as a critical focal point in the ongoing endeavor to unravel the complexities of HCMV pathogenesis and to create effective preventive measures against this widespread virus.